Abstract
One of the major obstacles for adoptive cell transfer (ACT) of T cells is the loss of effector function and proliferative ability of isolated antigen-specific T cells after prolonged ex vivo expansion. To overcome this issue, induced pluripotent stem cells (iPSCs), which have unlimited proliferation and differentiation potential, can be used to generate a large number of antigen-specific T cells. Here, we describe an efficient differentiation protocol for the generation of cytotoxic CD8+ T cells from human T cell-derived iPSCs (T-iPSCs). The protocol consists of three main steps including differentiation of T-iPSCs toward hematoendothelial progenitors (HEPs), co-culture of HEPs with OP9-DL1 cells, and stimulation of T cell receptor (TCR) signaling to obtain CD8 single-positive (SP) T cells. This culture system is simple and efficient; therefore, will offer a powerful tool for studying T cell development and applications in adoptive immunotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Duong CP, Yong CS, Kershaw MH, Slaney CY, Darcy PK (2015) Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic. Mol Immunol 67(2 Pt A):46–57
Migliori E, Chang M, Muranski P (2018) Restoring antiviral immunity with adoptive transfer of ex-vivo generated T cells. Curr Opin Hematol 25(6):486–493
June CH (2007) Adoptive T cell therapy for cancer in the clinic. J Clin Invest 117(6):1466–1476
Nishimura T, Kaneko S, Kawana-Tachikawa A, Tajima Y, Goto H, Zhu D et al (2013) Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12(1):114–126
Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gonen M et al (2013) Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat Biotechnol 31(10):928–933
Sturgeon CM, Ditadi A, Awong G, Kennedy M, Keller G (2014) Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol 32(6):554–561
Pearson S, Sroczynska P, Lacaud G, Kouskoff V (2008) The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 135(8):1525–1535
Ottersbach K (2019) Endothelial-to-haematopoietic transition: an update on the process of making blood. Biochem Soc Trans 47(2):591–601
Kennedy M, Awong G, Sturgeon CM, Ditadi A, Lamotte-Mohs R, Zúñiga-Pflücker JC et al (2012) T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2(6):1722–1735
Boehmer HV, Fehling HJ (1997) Structure and function of the pre-T cell receptor. Annu Rev Immunol 15(1):433–452
Anderson G, Moore NC, Owen JJ, Jenkinson EJ (1996) Cellular interactions in thymocyte development. Annu Rev Immunol 14:73–99
Schmitt TM, Zúñiga-Pflücker JC (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17(6):749–756
Maeda T, Nagano S, Ichise H, Kataoka K, Yamada D, Ogawa S et al (2016) Regeneration of CD8αβ T cells from T-cell-derived iPSC imparts potent tumor antigen-specific cytotoxicity. Cancer Res 76(23):6839–6850
Pear WS, Radtke F (2003) Notch signaling in lymphopoiesis. Semin Immunol 15(2):69–79
Wiles MV, Ruiz P, Imhof BA (1992) Interleukin-7 expression during mouse thymus development. Eur J Immunol 22(4):1037–1042
Moore NC, Anderson G, Smith CA, Owen JJT, Jenkinson EJ (1993) Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction. Eur J Immunol 23(4):922–927
Von Freeden-Jeffry U, Vieira P, Lucian LA, Mcneil T, Burdach SE, Murray R (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181(4):1519–1526
Godfrey DI, Zlotnik A, Suda T (1992) Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 149(7):2281–2285
Netsrithong, R, Suwanpitak, S, Boonkaew, B, Trakarnsanga, K, Chang, LJ, Tipgomut, C, Vatanashevanopakorn, C, Pattanapanyasat, K, Wattanapanitch, M (2020) Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells. Stem Cell Res & Ther 11(1):481
Netsrithong R, Promnakhon N, Boonkaew B, Vatanashevanopakorn C, Pattanapanyasat K, Wattanapanitch M (2019) Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual. Stem Cell Res 39:101487
Acknowledgments
This work was supported by Siriraj Research Fund, Faculty of Medicine Siriraj Hospital, Mahidol University (grant number (IO) R016234002 and R016333015), the Thailand Research Fund (grant no. RSA6280090), the Program Management Unit for Human Resources & Institutional Development, Research and Innovation (grant number B05F630080). NP is supported by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program and Faculty of Medicine Siriraj Hospital, Mahidol University (grant no. PHD/0203/2556). RN is supported by the Development and Promotion of Science and Technology Talents Project. MW is supported by Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Suwanpitak, S., Promnakhon, N., Netsrithong, R., Wattanapanitch, M. (2021). Efficient Generation of iPSC-Derived Hematoendothelial Progenitors and Specification Toward T cell Lineage. In: Nagy, A., Turksen, K. (eds) Induced Pluripotent Stem (iPS) Cells. Methods in Molecular Biology, vol 2454. Humana, New York, NY. https://doi.org/10.1007/7651_2021_355
Download citation
DOI: https://doi.org/10.1007/7651_2021_355
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2118-9
Online ISBN: 978-1-0716-2119-6
eBook Packages: Springer Protocols